Connect with us
CGIF-10th-Year-Anniversary

Health

Thailand aims to start COVID-19 vaccine human trials in October

Researchers are now gearing up for human clinical trials in October, with production starting in mid-2021, after a trial of a COVID-19 vaccine candidate in monkeys was successful

National News Bureau of Thailand

Published

on

BANGKOK (NNT) – A trial of a COVID-19 vaccine candidate in monkeys has been successful, with the subjects showing higher immune responses. Researchers are now gearing up for human clinical trials in October, with production starting in mid-2021.

A study of a COVID-19 vaccine prototype in monkeys, performed by the National Research Council of Thailand (NRCT) and Chulalongkorn University’s National Primate Research Center of Thailand, has been successful, according to the NRCT.

This experimental mRNA vaccine had first been successfully tested in rats, while the tests in monkeys started on 23 May.

The Minister of Higher Education, Science, Research and Innovation, Suvit Maesincee, said all the monkeys that received the vaccine show no negative side effects, while their blood tests show a satisfactory level of the antibody triggered by the vaccine.

The monkeys, at the National Primate Research Center, have been injected with the vaccine once. Researchers will today administer the second dose for further study. Should all go well, the clinical trial of this vaccine candidate in humans can begin in October and November this year.

The NRCT Secretary General Dr. Sirirurg Songsivilai said the monkeys will be tested periodically for their immune responses after receiving the second dose of vaccine, with their antibody level expected to increase over the next two weeks, while the third dose will be administered in August.

He said this research project is now progressing on track, with the target to start producing a viable COVID-19 vaccine in Thailand in mid-2021.

The National Primate Research Center Director Suchinda Malaivijitnond said the experimental vaccine has shown no negative side effects in recipient monkeys with no fever, or symptoms in the neurological, cardiovascular, respiratory or digestive systems.

The monkeys are showing normal behaviour, which is a good sign that this vaccine prototype would be safe for use in humans.

She said the project shows the world-class capabilities of vaccine researchers and development projects in Thailand.

Comments

Companies

Thai Firm to produce 200 million doses of Covid-19 vaccine

Thai Firm Siam Bioscience Joins with AstraZeneca to Make COVID-19 Vaccine for Southeast Asia and says it will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year.

Olivier Languepin

Published

on

Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.

(more…)
Continue Reading

Health

The Latest on Covid-19 in Southeast Asia

Even in Southeast Asia, which has fared comparatively well in minimizing deaths, economies have either ground to a halt or deeply contracted due to the region’s reliance on exports and tourism.

Pr News

Published

on

By

It would be an understatement to describe 2020 as a challenging year. Coronavirus swept the globe and over 1.6 million people have died from the disease.

(more…)
Continue Reading

Health

Covid-19 is not the biggest health crisis in Thailand

For many years, Thailand has earned notoriety in the area of road fatalities: Thailand’s roads are the deadliest in Southeast Asia and among the worst in the world, according to the World Health Organisation

Avatar

Published

on

If we go by the number of deaths, the coronavirus is not the country’s biggest health public health problem. Road accidents are.

(more…)
Continue Reading
Advertisement

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,413 other subscribers

Trending